Wyeth Rejects Claim That It Promoted Off-Label Prescribing
Pfizer's Wyeth Pharmaceuticals Inc. on Thursday told a Massachusetts federal court that a whistleblower can't prove the drugmaker encouraged physicians to prescribe its acid reflux drug off label, as part of...To view the full article, register now.
Already a subscriber? Click here to view full article